Marshall Wace
BDSX icon

Marshall Wace’s Biodesix BDSX Stock Holding History

Marshall Wace’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Buy
+141,636
New +$1.76M ﹤0.01% 1769
2025
Q2 		– Sell
-4,406
Closed -$55.5K – 2708
2025
Q1 		$55.5K Buy
4,406
+3,653
+485% +$70.1K ﹤0.01% 2530
2024
Q4 		$23K Buy
+753
New +$22.2K ﹤0.01% 2507

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Marshall Wace's BDSX Position: Q1 2026 in Review

Marshall Wace opened a new position in Biodesix (BDSX) in Q1 2026: 141,636 shares worth $2.05M. The stake represents ﹤0.01% of the portfolio and ranks #1769 among its holdings. This is a return to the name: Marshall Wace previously reported a position in BDSX as recently as Q1 2025.

Marshall Wace first reported a position in BDSX in Q4 2024 and has held it in 3 quarters since. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Marshall Wace held 141,636 shares of Biodesix worth $2.05M as of Q1 2026.
  • Biodesix was a new Marshall Wace position in Q1 2026.
  • Biodesix made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1769 holding.
  • Marshall Wace first reported a position in Biodesix in Q4 2024 and has held it in 3 quarters since.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.